DB05712ExperimentalSmall molecule
AZD-9684 is the first member of a new anti-thrombotic class (CPU inhibitors). It is being developed by AstraZeneca.
- Mechanism
- Curator reviewed
AZD-9684 is a Carboxypeptidase U inhibitor (CPUi).
- Primary indication
- Investigated for use/treatment in thrombosis.Curator reviewed
- Code names
- AZD9684
Resolves to
Compound
What you can answer from here — as of March 06, 2025
5Protein targetsEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with AZD-9684, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account